IMMUCELL CORP /DE/ Net Income Loss

• IMMUCELL CORP /DE/ showed an increase of +51.8% in Net Income Loss from 2024 to 2025.
• This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2012: -$63.6 thousand | Q4 2012: -$16.9 thousand | Q1 2013: $204.3 thousand | Q2 2013: $6.5 thousand | Q3 2013: $57.3 thousand | Q4 2013: -$150.7 thousand | Q1 2014: -$13.3 thousand | Q2 2014: -$294.8 thousand | Q3 2014: $10.3 thousand | Q4 2014: $130.6 thousand | Q1 2015: $479.1 thousand | Q2 2015: $94.1 thousand | Q3 2015: $351.3 thousand | Q4 2015: $288.8 thousand | Q1 2016: $452.4 thousand | Q2 2016: -$9.2 thousand | Q3 2016: $34.9 thousand | Q4 2016: $30.3 thousand | Q1 2017: $584.2 thousand | Q2 2017: -$218.4 thousand | Q3 2017: -$339.3 thousand | Q1 2018: -$221.1 thousand | Q2 2018: -$798.4 thousand | Q3 2018: -$250.0 thousand | Q1 2019: $144.6 thousand | Q2 2019: -$627.2 thousand | Q3 2019: -$502.5 thousand | Q1 2020: -$122.3 thousand | Q2 2020: -$765.8 thousand | Q3 2020: -$322.9 thousand | Q1 2021: -$441.3 thousand | Q2 2021: $141.1 thousand | Q3 2021: $147.8 thousand | Q1 2022: $513.3 thousand | Q2 2022: -$684.1 thousand | Q3 2022: -$655.1 thousand | Q1 2023: -$2.32 million | Q2 2023: -$1.38 million | Q3 2023: -$940.0 thousand | Q1 2024: -$437.9 thousand | Q2 2024: -$1.53 million | Q3 2024: -$701.7 thousand | Q1 2025: $1.45 million | Q2 2025: $501.9 thousand | Q3 2025: -$139.7 thousand.
• Over the full 17 years of available data (2009 to 2025), IMMUCELL CORP /DE/'s Net Income Loss has declined by 380.4%.
• Historical annual values: Fiscal year 2025: -$1.04 million | Fiscal year 2024: -$2.16 million | Fiscal year 2023: -$5.77 million | Fiscal year 2022: -$2.49 million | Fiscal year 2021: -$78.3 thousand | Fiscal year 2020: -$1.02 million | Fiscal year 2019: -$1.30 million | Fiscal year 2018: -$2.32 million | Fiscal year 2017: -$168.1 thousand | Fiscal year 2016: $508.4 thousand | Fiscal year 2015: $1.21 million | Fiscal year 2014: -$167.2 thousand | Fiscal year 2013: $117.4 thousand | Fiscal year 2012: $89.5 thousand | Fiscal year 2011: -$409.5 thousand | Fiscal year 2010: -$384.7 thousand | Fiscal year 2009: -$216.5 thousand.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026